Sylvia K. Plevritis - Publications

Stanford University, Palo Alto, CA 
Statistics, Public Health, Operations Research, Oncology, Biostatistics Biology

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Meza R, Jeon J, Toumazis I, Ten Haaf K, Cao P, Bastani M, Han SS, Blom EF, Jonas DE, Feuer EJ, Plevritis SK, de Koning HJ, Kong CY. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force. Jama. 325: 988-997. PMID 33687469 DOI: 10.1001/jama.2021.1077  0.52
2020 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Plos Medicine. 17: e1003403. PMID 32976487 DOI: 10.1371/journal.pmed.1003403  0.52
2020 Toumazis I, Bastani M, Han SS, Plevritis SK. Risk-Based lung cancer screening: A systematic review. Lung Cancer (Amsterdam, Netherlands). 147: 154-186. PMID 32721652 DOI: 10.1016/j.lungcan.2020.07.007  0.52
2020 Gentles AJ, Hui AB, Feng W, Azizi A, Nair RV, Bouchard G, Knowles DA, Yu A, Jeong Y, Bejnood A, Forgó E, Varma S, Xu Y, Kuong A, Nair VS, ... ... Plevritis SK, et al. A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome Biology. 21: 107. PMID 32381040 DOI: 10.1186/s13059-020-02019-x  0.48
2020 Han SS, Chow E, Ten Haaf K, Toumazis I, Cao P, Bastani M, Tammemagi M, Jeon J, Feuer E, Meza R, Plevritis S. Disparities of national lung cancer screening guidelines in the U.S. population. Journal of the National Cancer Institute. PMID 32040195 DOI: 10.1093/jnci/djaa013  0.52
2019 Toumazis I, Tsai EB, Erdogan SA, Han SS, Wan W, Leung A, Plevritis SK. Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings. Jnci Cancer Spectrum. 3: pkz035. PMID 31942534 DOI: 10.1093/jncics/pkz035  0.52
2019 Karacosta LG, Anchang B, Ignatiadis N, Kimmey SC, Benson JA, Shrager JB, Tibshirani R, Bendall SC, Plevritis SK. Mapping lung cancer epithelial-mesenchymal transition states and trajectories with single-cell resolution. Nature Communications. 10: 5587. PMID 31811131 DOI: 10.1038/s41467-019-13441-6  0.48
2019 Criss SD, Cao P, Bastani M, Ten Haaf K, Chen Y, Sheehan DF, Blom EF, Toumazis I, Jeon J, de Koning HJ, Plevritis SK, Meza R, Kong CY. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study. Annals of Internal Medicine. PMID 31683314 DOI: 10.7326/M19-0322  0.52
2019 Ten Haaf K, Bastani M, Cao P, Jeon J, Toumazis I, Han SS, Plevritis SK, Blom EF, Kong CY, Tammemägi MC, Feuer EJ, Meza R, de Koning HJ. A comparative modeling analysis of risk-based lung cancer screening strategies. Journal of the National Cancer Institute. PMID 31566216 DOI: 10.1093/jnci/djz164  0.52
2018 Han SS, Plevritis SK, Wakelee HA. Caution Needed for Analyzing the Risks of Second Cancers. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 13: e172-e173. PMID 30166015 DOI: 10.1016/j.jtho.2018.04.018  0.52
2018 Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, ... Plevritis SK, et al. GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Research. PMID 29760045 DOI: 10.1158/0008-5472.CAN-17-2928  0.48
2018 Anchang B, Davis KL, Fienberg HG, Williamson BD, Bendall SC, Karacosta LG, Tibshirani R, Nolan GP, Plevritis SK. DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity. Proceedings of the National Academy of Sciences of the United States of America. PMID 29654148 DOI: 10.1073/pnas.1711365115  0.48
2017 Han SS, Ten Haaf K, Hazelton WD, Jeon J, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. Re: Think Before You Leap. International Journal of Cancer. PMID 29194597 DOI: 10.1002/ijc.31183  0.52
2017 Zhou M, Leung A, Echegaray S, Gentles A, Shrager JB, Jensen KC, Berry GJ, Plevritis SK, Rubin DL, Napel S, Gevaert O. Non-Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications. Radiology. 161845. PMID 28727543 DOI: 10.1148/radiol.2017161845  0.48
2017 Han SS, Erdogan SA, Toumazis I, Leung A, Plevritis SK. Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model. Cancer Causes & Control : Ccc. PMID 28702814 DOI: 10.1007/s10552-017-0907-x  0.52
2017 Han SS, Rivera GA, Tammemägi MC, Plevritis SK, Gomez SL, Cheng I, Wakelee HA. Risk Stratification for Second Primary Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017724203. PMID 28644772 DOI: 10.1200/JCO.2017.72.4203  0.52
2017 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R. Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. Plos Medicine. 14: e1002277. PMID 28376113 DOI: 10.1371/journal.pmed.1002277  0.52
2017 Han SS, Ten Haaf K, Hazelton WD, Munshi VN, Jeon J, Erdogan SA, Johanson C, McMahon PM, Meza R, Kong CY, Feuer EJ, de Koning HJ, Plevritis SK. The impact of overdiagnosis on the selection of efficient lung cancer screening strategies. International Journal of Cancer. PMID 28073150 DOI: 10.1002/ijc.30602  0.52
2016 Anchang B, Hart TD, Bendall SC, Qiu P, Bjornson Z, Linderman M, Nolan GP, Plevritis SK. Visualization and cellular hierarchy inference of single-cell data using SPADE. Nature Protocols. 11: 1264-1279. PMID 27310265 DOI: 10.1038/nprot.2016.066  1
2015 Gentles AJ, Bratman SV, Lee LJ, Harris JP, Feng W, Nair RV, Shultz DB, Nair VS, Hoang CD, West RB, Plevritis SK, Alizadeh AA, Diehn M. Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer. Journal of the National Cancer Institute. 107. PMID 26286589 DOI: 10.1093/jnci/djv211  0.48
2015 Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, Diehn M, West RB, Plevritis SK, Alizadeh AA. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nature Medicine. 21: 938-45. PMID 26193342 DOI: 10.1038/nm.3909  0.48
2015 Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK. Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features. Radiology. 276: 313. PMID 26101929 DOI: 10.1148/radiol.2015154019  1
2015 Green MR, Kihira S, Liu CL, Nair RV, Salari R, Gentles AJ, Irish J, Stehr H, Vicente-Dueñas C, Romero-Camarero I, Sanchez-Garcia I, Plevritis SK, Arber DA, Batzoglou S, Levy R, et al. Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation. Proceedings of the National Academy of Sciences of the United States of America. 112: E1116-25. PMID 25713363 DOI: 10.1073/pnas.1501199112  1
2015 Gevaert O, Tibshirani R, Plevritis SK. Pancancer analysis of DNA methylation-driven genes using MethylMix. Genome Biology. 16: 17. PMID 25631659 DOI: 10.1186/s13059-014-0579-8  0.48
2014 de Koning HJ, Meza R, Plevritis SK. Raising the bar for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 161: 532-3. PMID 25285549 DOI: 10.7326/L14-5019-3  1
2014 Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, Burnside ES, Chang Y, Chisholm G, de Koning HJ, Ali Ergun M, Heijnsdijk EA, Huang H, Stout NK, ... ... Plevritis SK, et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. Journal of the National Cancer Institute. 106. PMID 25255803 DOI: 10.1093/jnci/dju289  1
2014 McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, et al. Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. Plos One. 9: e99978. PMID 24979231 DOI: 10.1371/journal.pone.0099978  1
2014 Li X, Nadauld L, Ootani A, Corney DC, Pai RK, Gevaert O, Cantrell MA, Rack PG, Neal JT, Chan CWM, Yeung T, Gong X, Yuan J, Wilhelmy J, Robine S, ... ... Plevritis SK, et al. Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture Nature Medicine. 20: 769-777. PMID 24859528 DOI: 10.1038/nm.3585  1
2014 Gevaert O, Mitchell LA, Achrol AS, Xu J, Echegaray S, Steinberg GK, Cheshier SH, Napel S, Zaharchuk G, Plevritis SK. Glioblastoma multiforme: exploratory radiogenomic analysis by using quantitative image features. Radiology. 273: 168-74. PMID 24827998 DOI: 10.1148/radiol.14131731  1
2014 Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, ... ... Plevritis SK, et al. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. Cancer. 120: 1713-24. PMID 24577803 DOI: 10.1002/cncr.28623  1
2014 de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, Erdogan SA, Kong CY, Han SS, van Rosmalen J, Choi SE, Pinsky PF, Berrington de Gonzalez A, Berg CD, Black WC, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Annals of Internal Medicine. 160: 311-20. PMID 24379002 DOI: 10.7326/M13-2316  1
2014 Nair VS, Gevaert O, Davidzon G, Plevritis SK, West R. NF-κB protein expression associates with (18)F-FDG PET tumor uptake in non-small cell lung cancer: a radiogenomics validation study to understand tumor metabolism. Lung Cancer (Amsterdam, Netherlands). 83: 189-96. PMID 24355259 DOI: 10.1016/j.lungcan.2013.11.001  1
2013 Gevaert O, Villalobos V, Sikic BI, Plevritis SK. Identification of ovarian cancer driver genes by using module network integration of multi-omics data. Interface Focus. 3: 20130013. PMID 24511378 DOI: 10.1098/rsfs.2013.0013  1
2013 Tan D, Horning SJ, Hoppe RT, Levy R, Rosenberg SA, Sigal BM, Warnke RA, Natkunam Y, Han SS, Yuen A, Plevritis SK, Advani RH. Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood. 122: 981-7. PMID 23777769 DOI: 10.1182/blood-2013-03-491514  1
2013 Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL, Kela I, Hopmans ES, Myklebust JH, Ji H, Plevritis SK, Levy R, Alizadeh AA. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood. 121: 1604-11. PMID 23297126 DOI: 10.1182/blood-2012-09-457283  1
2013 Qiu P, Plevritis SK. TreeVis: a MATLAB-based tool for tree visualization. Computer Methods and Programs in Biomedicine. 109: 74-6. PMID 23036855 DOI: 10.1016/j.cmpb.2012.08.008  1
2012 Linderman MD, Bjornson Z, Simonds EF, Qiu P, Bruggner RV, Sheode K, Meng TH, Plevritis SK, Nolan GP. CytoSPADE: high-performance analysis and visualization of high-dimensional cytometry data. Bioinformatics (Oxford, England). 28: 2400-1. PMID 22782546 DOI: 10.1093/bioinformatics/bts425  1
2012 Gevaert O, Xu J, Hoang CD, Leung AN, Xu Y, Quon A, Rubin DL, Napel S, Plevritis SK. Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results. Radiology. 264: 387-96. PMID 22723499 DOI: 10.1148/radiol.12111607  1
2012 Nair VS, Gevaert O, Davidzon G, Napel S, Graves EE, Hoang CD, Shrager JB, Quon A, Rubin DL, Plevritis SK. Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer. Cancer Research. 72: 3725-34. PMID 22710433 DOI: 10.1158/0008-5472.CAN-11-3943  1
2012 Sigal BM, Munoz DF, Kurian AW, Plevritis SK. A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1066-77. PMID 22556274 DOI: 10.1158/1055-9965.EPI-12-0149  0.52
2012 Kani K, Faca VM, Hughes LD, Zhang W, Fang Q, Shahbaba B, Luethy R, Erde J, Schmidt J, Pitteri SJ, Zhang Q, Katz JE, Gross ME, Plevritis SK, McIntosh MW, et al. Quantitative proteomic profiling identifies protein correlates to EGFR kinase inhibition. Molecular Cancer Therapeutics. 11: 1071-81. PMID 22411897 DOI: 10.1158/1535-7163.MCT-11-0852  1
2011 Mandelblatt JS, Cronin KA, Berry DA, Chang Y, de Koning HJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, van Ravesteyn NT, Zelen M, Feuer EJ. Modeling the impact of population screening on breast cancer mortality in the United States. Breast (Edinburgh, Scotland). 20: S75-81. PMID 22015298 DOI: 10.1016/S0960-9776(11)70299-5  1
2011 Choi PS, van Riggelen J, Gentles AJ, Bachireddy P, Rakhra K, Adam SJ, Plevritis SK, Felsher DW. Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction. Proceedings of the National Academy of Sciences of the United States of America. 108: 17432-7. PMID 21969595 DOI: 10.1073/pnas.1107303108  1
2011 Qiu P, Simonds EF, Bendall SC, Gibbs KD, Bruggner RV, Linderman MD, Sachs K, Nolan GP, Plevritis SK. Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nature Biotechnology. 29: 886-91. PMID 21964415 DOI: 10.1038/nbt.1991  1
2011 Shahbaba B, Tibshirani R, Shachaf CM, Plevritis SK. Bayesian gene set analysis for identifying significant biological pathways. Journal of the Royal Statistical Society. Series C, Applied Statistics. 60: 541-557. PMID 21857748 DOI: 10.1111/j.1467-9876.2011.00765.x  0.48
2011 Qiu P, Plevritis SK. Reconstructing directed signed gene regulatory network from microarray data. Ieee Transactions On Bio-Medical Engineering. 58: 3518-21. PMID 21803675 DOI: 10.1109/TBME.2011.2163188  1
2011 Alizadeh AA, Gentles AJ, Alencar AJ, Liu CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH, Gascoyne RD, Briones J, Tibshirani RJ, Myklebust JH, Plevritis SK, et al. Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment. Blood. 118: 1350-8. PMID 21670469 DOI: 10.1182/blood-2011-03-345272  1
2011 Bendall SC, Simonds EF, Qiu P, Amir el-AD, Krutzik PO, Finck R, Bruggner RV, Melamed R, Trejo A, Ornatsky OI, Balderas RS, Plevritis SK, Sachs K, Pe'er D, Tanner SD, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science (New York, N.Y.). 332: 687-96. PMID 21551058 DOI: 10.1126/science.1198704  1
2011 Qiu P, Gentles AJ, Plevritis SK. Discovering biological progression underlying microarray samples. Plos Computational Biology. 7: e1001123. PMID 21533210 DOI: 10.1371/journal.pcbi.1001123  0.48
2010 Gentles AJ, Plevritis SK, Majeti R, Alizadeh AA. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. Jama. 304: 2706-15. PMID 21177505 DOI: 10.1001/jama.2010.1862  1
2010 Bailey SL, Sigal BM, Plevritis SK. A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. Journal of the National Cancer Institute. 102: 1263-71. PMID 20664027 DOI: 10.1093/jnci/djq271  1
2010 Lee CI, Tsai EB, Sigal BM, Plevritis SK, Garber AM, Rubin GD. Incidental extracardiac findings at coronary CT: clinical and economic impact. Ajr. American Journal of Roentgenology. 194: 1531-8. PMID 20489093 DOI: 10.2214/AJR.09.3587  0.52
2010 Sahoo D, Seita J, Bhattacharya D, Inlay MA, Weissman IL, Plevritis SK, Dill DL. MiDReG: a method of mining developmentally regulated genes using Boolean implications. Proceedings of the National Academy of Sciences of the United States of America. 107: 5732-7. PMID 20231483 DOI: 10.1073/pnas.0913635107  1
2010 Qiu P, Gentles AJ, Plevritis SK. Reducing the computational complexity of information theoretic approaches for reconstructing gene regulatory networks. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 17: 169-76. PMID 20078227 DOI: 10.1089/cmb.2009.0052  0.48
2010 Kurian AW, Sigal BM, Plevritis SK. Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 222-31. PMID 19996031 DOI: 10.1200/JCO.2009.22.7991  1
2009 Sachs K, Gentles AJ, Youland R, Itani S, Irish J, Nolan GP, Plevritis SK. Characterization of patient specific signaling via augmentation of Bayesian networks with disease and patient state nodes. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2009: 6624-7. PMID 19963681 DOI: 10.1109/IEMBS.2009.5332563  1
2009 Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Annals of Internal Medicine. 151: 738-47. PMID 19920274 DOI: 10.7326/0003-4819-151-10-200911170-00010  1
2009 Inlay MA, Bhattacharya D, Sahoo D, Serwold T, Seita J, Karsunky H, Plevritis SK, Dill DL, Weissman IL. Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. Genes & Development. 23: 2376-81. PMID 19833765 DOI: 10.1101/gad.1836009  1
2009 Gentles AJ, Alizadeh AA, Lee SI, Myklebust JH, Shachaf CM, Shahbaba B, Levy R, Koller D, Plevritis SK. A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients. Blood. 114: 3158-66. PMID 19636063 DOI: 10.1182/blood-2009-02-202465  1
2009 Pashkevich MA, Sigal BM, Plevritis SK. Modeling the transition of lung cancer from early to advanced stage. Cancer Causes & Control : Ccc. 20: 1559-69. PMID 19629730 DOI: 10.1007/s10552-009-9401-4  0.52
2009 Qiu P, Plevritis SK. Simultaneous class discovery and classification of microarray data using spectral analysis. Journal of Computational Biology : a Journal of Computational Molecular Cell Biology. 16: 935-44. PMID 19580522 DOI: 10.1089/cmb.2008.0227  1
2009 Qiu P, Gentles AJ, Plevritis SK. Fast calculation of pairwise mutual information for gene regulatory network reconstruction. Computer Methods and Programs in Biomedicine. 94: 177-80. PMID 19167129 DOI: 10.1016/j.cmpb.2008.11.003  0.48
2009 Shahbaba B, Gentles AJ, Beyene J, Plevritis SK, Greenwood CMT. A Bayesian nonparametric method for model evaluation: Application to genetic studies Journal of Nonparametric Statistics. 21: 379-396. DOI: 10.1080/10485250802613558  1
2008 Sahoo D, Dill DL, Gentles AJ, Tibshirani R, Plevritis SK. Boolean implication networks derived from large scale, whole genome microarray datasets. Genome Biology. 9: R157. PMID 18973690 DOI: 10.1186/gb-2008-9-10-r157  1
2008 Shachaf CM, Gentles AJ, Elchuri S, Sahoo D, Soen Y, Sharpe O, Perez OD, Chang M, Mitchel D, Robinson WH, Dill D, Nolan GP, Plevritis SK, Felsher DW. Genomic and proteomic analysis reveals a threshold level of MYC required for tumor maintenance Cancer Research. 68: 5132-5142. PMID 18593912 DOI: 10.1158/0008-5472.CAN-07-6192  1
2007 Sahoo D, Dill DL, Tibshirani R, Plevritis SK. Extracting binary signals from microarray time-course data. Nucleic Acids Research. 35: 3705-12. PMID 17517782 DOI: 10.1093/nar/gkm284  1
2007 Ghanouni P, Kurian AW, Margolis D, Hartman AR, Mills MA, Plevritis SK, Ford JM, Daniel BL. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage. The Breast Journal. 13: 281-6. PMID 17461903 DOI: 10.1111/j.1524-4741.2007.00422.x  1
2007 Plevritis SK, Salzman P, Sigal BM, Glynn PW. A natural history model of stage progression applied to breast cancer. Statistics in Medicine. 26: 581-95. PMID 16598706 DOI: 10.1002/sim.2550  1
2006 Cronin KA, Feuer EJ, Clarke LD, Plevritis SK. Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. Journal of the National Cancer Institute. Monographs. 112-21. PMID 17032901 DOI: 10.1093/jncimonographs/lgj015  1
2006 Clarke LD, Plevritis SK, Boer R, Cronin KA, Feuer EJ. A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. Journal of the National Cancer Institute. Monographs. 96-105. PMID 17032899 DOI: 10.1093/jncimonographs/lgj013  1
2006 Plevritis SK, Sigal BM, Salzman P, Rosenberg J, Glynn P. A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000. Journal of the National Cancer Institute. Monographs. 86-95. PMID 17032898 DOI: 10.1093/jncimonographs/lgj012  1
2006 Plevritis SK, Kurian AW, Sigal BM, Daniel BL, Ikeda DM, Stockdale FE, Garber AM. Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. Jama. 295: 2374-84. PMID 16720823 DOI: 10.1001/jama.295.20.2374  1
2005 Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ. Effect of screening and adjuvant therapy on mortality from breast cancer. The New England Journal of Medicine. 353: 1784-92. PMID 16251534 DOI: 10.1056/NEJMoa050518  1
2005 Kurian AW, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1082-9. PMID 15894656 DOI: 10.1158/1055-9965.EPI-04-0776  0.52
2004 Chia YL, Salzman P, Plevritis SK, Glynn PW. Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration. Statistical Methods in Medical Research. 13: 507-24. PMID 15587436 DOI: 10.1191/0962280204sm380ra  1
2002 Plevritis SK, Ikeda DM. Ethical issues in contrast-enhanced magnetic resonance imaging screening for breast cancer. Topics in Magnetic Resonance Imaging : Tmri. 13: 79-84. PMID 12055452 DOI: 10.1097/00002142-200204000-00003  1
1995 Plevritis SK, Macovski A. Spectral Extrapolation of Spatially Bounded Images Ieee Transactions On Medical Imaging. 14: 487-497. DOI: 10.1109/42.414614  1
1991 Plevritis SK, Macovski A. Resolution improvement for in-vivo magnetic resonance spectroscopic images Proceedings of Spie - the International Society For Optical Engineering. 1445: 118-127.  1
Show low-probability matches.